Publication | Open Access

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

Breast OncologyMedicineYear Follow-up StudyPathologyBreast CancerOperable Breast CancerDermatologyOncologyRadiation OncologyCancer GrowthNode Negative Subgroup